Literature DB >> 12789320

Cancer: Out of air is not out of action.

Donald P Bottaro, Lance A Liotta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12789320     DOI： 10.1038/423593a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  54 in total

1.  Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.

Authors:  Adam C Yopp; Lawrence H Schwartz; Nancy Kemeny; David H Gultekin; Mithat Gönen; Zubin Bamboat; Jinru Shia; Dana Haviland; Michael I D'Angelica; Yuman Fong; Ronald P DeMatteo; Peter J Allen; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2011-02-01       Impact factor: 5.344

Review 2.  Heralding a new paradigm in 3D tumor modeling.

Authors:  Eliza L S Fong; Daniel A Harrington; Mary C Farach-Carson; Hanry Yu
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

3.  Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model.

Authors:  Danielle J McCullough; Linda M-D Nguyen; Dietmar W Siemann; Bradley J Behnke
Journal:  J Appl Physiol (1985)       Date:  2013-10-31

4.  MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.

Authors:  Xuguang Zheng; Michael Chopp; Yong Lu; Benjamin Buller; Feng Jiang
Journal:  Cancer Lett       Date:  2012-11-07       Impact factor: 8.679

5.  VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer.

Authors:  Weon-Kyoo You; Barbara Sennino; Casey W Williamson; Beverly Falcón; Hiroya Hashizume; Li-Chin Yao; Dana T Aftab; Donald M McDonald
Journal:  Cancer Res       Date:  2011-05-25       Impact factor: 12.701

6.  Histology-based expression profiling yields novel prognostic markers in human glioblastoma.

Authors:  Shumin Dong; Catherine L Nutt; Rebecca A Betensky; Anat O Stemmer-Rachamimov; Nicholas C Denko; Keith L Ligon; David H Rowitch; David N Louis
Journal:  J Neuropathol Exp Neurol       Date:  2005-11       Impact factor: 3.685

Review 7.  New treatments for bladder cancer: when will we make progress?

Authors:  Rosa Nadal; Joaquim Bellmunt
Journal:  Curr Treat Options Oncol       Date:  2014-03

8.  Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia.

Authors:  Alessia Bottos; Miriam Martini; Federica Di Nicolantonio; Valentina Comunanza; Federica Maione; Alberto Minassi; Giovanni Appendino; Federico Bussolino; Alberto Bardelli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

Review 9.  Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods.

Authors:  Bishnu P Joshi; Joseph Hardie; Michelle E Farkas
Journal:  Chemistry       Date:  2018-05-14       Impact factor: 5.236

Review 10.  Targeting molecular aberrations in urothelial carcinoma: are we almost there?

Authors:  Andrea B Apolo; David J Kwiatkowski
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.